Be precise, be reproducible! the emerging role of artificial intelligence in inflammatory bowel disease endoscopy (2025) Tontini GE, Rath T Journal article Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies (2025) Atreya R, Ferrante M, Panaccione R, Feagan B, Shchukina O, Jairath V, Rieder F, et al. Journal article IL-23R-Specific Chimeric Antigen Receptor Tregs in Crohn's Disease: Dawn of a Cellular Immunotherapeutic Era? (2025) Atreya R, Neurath M Journal article, Editorial Comparative real-world effectiveness of ustekinumab versus anti-TNF in Crohn's disease: 12-month maintenance phase results from the prospective, observational RUN-CD study using propensity score adjustment (2025) Bokemeyer B, Plachta-Danielzik S, Gilman E, Di Giuseppe R, Deppe H, Mohl W, Teich N, et al. Journal article Integrin αVβ6: Autoantigen and Driver of Epithelial Remodeling in Colon and Bile Ducts in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease. (2025) Roth D, Düll M, Horst LJ, Lindemann A, Malzer X, Koop K, Zundler S, et al. Journal article ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment (2024) Adamina M, Minozzi S, Warusavitarne J, Buskens CJ, Chaparro M, Verstockt B, Kopylov U, et al. Journal article Spatial Single Cell Profiling Using Imaging Mass Cytometry: Inflammatory Versus Penetrating Crohn's Disease (2024) Lehmann M, Weixler B, Elezkurtaj S, Loddenkemper C, Atreya I, Atreya R, Bacher P, et al. Journal article PragmaticTrial Design to Compare Real-world Effectiveness of DifferentTreatments for Inflammatory Bowel Diseases:The PRACTICE-IBD European Consensus (2024) Fantini MC, Fiorino G, Colli A, Laharie D, Armuzzi A, Caprioli FA, Gisbert JP, et al. Journal article Blocking GPR15 Counteracts Integrin-dependent T Cell Gut Homing in Vivo (2024) Schramm S, Liu L, Saad M, Dietz L, Dedden M, Müller T, Atreya I, et al. Journal article Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial. (2024) Atreya R, Kühbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, et al. Journal article